Jeffrey R. Jay’s AMAG Pharmaceuticals AMAG Stock Holding History

Jeffrey R. Jay’s Portfolio AMAG Stock Details AMAG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q2	$3K	Buy	+150	New	+$3.31K	﹤0.01%	32

Other funds holding AMAG

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Jeffrey R. Jay's AMAG Position: Q2 2013 in Review

Jeffrey R. Jay opened a new position in AMAG Pharmaceuticals (AMAG) in Q2 2013: 150 shares worth $3K. The stake represents ﹤0.01% of the portfolio and ranks #32 among its holdings.

96 funds tracked by Wall St. Rank hold AMAG as of Q2 2013.

Jeffrey R. Jay held 150 shares of AMAG Pharmaceuticals worth $3K as of Q2 2013.
AMAG Pharmaceuticals was a new Jeffrey R. Jay position in Q2 2013.
AMAG Pharmaceuticals made up ﹤0.01% of Jeffrey R. Jay's portfolio in Q2 2013, its #32 holding.
96 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q2 2013.

Based on Jeffrey R. Jay's 13F filing for Q2 2013, filed 14 Aug 2013.